In order to examine the effect of RIPC on skeleton muscle exertional damage and on aerobic and anaerobic physical performances, 30 healthy volunteers will undergo a series of different physical tests twice; once without intervention and a second time with RIPC intervention or placebo (false) intervention.
30 healthy civilians volunteers will be recruited and divided randomly into 2 groups: RIPC group and control group. The experiment protocol consist 2 series (with a month between them), both series include the described 3 days: Day 1 - anthropometry measurements and VO2max test (BRUCE protocol). Day 2 - steps test (heled protocol). Day 3 - anaerobic test (wingate protocol), 1 hour rest and time to exhaustion test (heled protocol). The first series will be performed without applying any intervention and is considered as baseline measurements for both groups. the second series will be performed as follows: a. RIPC group: applying RIPC exposure (placing a sphygmomanometer on the non-dominant hand and applying pressure of 200 mmHg for 5 min followed by 5 min without pressure X 4 repeats) at the beginning of every meeting. b. control group: with placebo (false) exposure (placing a sphygmomanometer on the non-dominant hand and applying pressure of 100 mmHg for 5 min followed by 5 min without pressure X 4 repeats) at the beginning of every meeting. Blood ample, lactic acid and urine sample will be tested at the beginning and end of every meeting (testing for muscle, skeleton and kidney function markers).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Enrollment
30
placing a sphygmomanometer on the non-dominant hand and applying pressure of 200 mmHg for 5 min followed by 5 min without pressure X 4 repeats
placing a sphygmomanometer on the non-dominant hand and applying pressure of 100 mmHg for 5 min followed by 5 min without pressure X 4 repeats.
Sheba medical center
Tel Litwinsky, Ramat- Gan, Israel
creatine phosphokinase (CPK)
CPK is a marker for muscle damage assessed in blood test. blood sample will be taken before and after step test, anaerobic test and time to exhaustion test.
Time frame: 6 experiment days for each participant
oxygen consumption (VO2)
VO2 will be monitored continuously using a metabolic system (ERGOTEST 680, ZAN, GERMANY ) during VO2max test and time to exhaustion test
Time frame: 6 experiment days for each participant
heart rate variability (HRV)
HRV will be measured using a wearable heart rate monitor (Polar® sensor and heart rate monitor watch) at rest for 10 min, before and after RIPC. data will be analysed by an expert.
Time frame: 6 experiment days for each participant
lactic acid
lactic acid level is assessed from blood drop (finger sting), will be taken before and after every test. lactic acid is a marker for anaerobic effort evaluating.
Time frame: 6 experiment days for each participant
blood count
blood counts are done to monitor overall health and to confirm a diagnosis of some medical conditions.
Time frame: 6 experiment days for each participant
apolipoprotein A1 (APO-A1) levels
APO-A1 is measured in blood chemistry as a marker for cholesterol.
Time frame: 6 experiment days for each participant
renal function (composite)
renal function (in order or not) will be evaluated from two markers measured in blood sample (chemistry): creatinine and urea.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 6 experiment days for each participant
inflammation (composite)
C-reactive protein (CRP) and blood sedimentation rate (assessed from blood sample) are indicators for inflammation.
Time frame: 6 experiment days for each participant
heart rate
HR will be monitored during the physical tests using a wearable heart rate monitor (Polar® sensor and heart rate monitor watch).
Time frame: 6 experiment days for each participant